Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9475043rdf:typepubmed:Citationlld:pubmed
pubmed-article:9475043lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9475043lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:9475043lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:9475043lifeskim:mentionsumls-concept:C0043272lld:lifeskim
pubmed-article:9475043lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:9475043lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:9475043pubmed:issue10lld:pubmed
pubmed-article:9475043pubmed:dateCreated1998-3-19lld:pubmed
pubmed-article:9475043pubmed:abstractTextImmunoaffinity column using Setaria digitata antigens coupled to cyanogen bromide activated Sepharose 4B beads were developed to purify antibodies from sera of filarial patients. Chaotropic (KSCN) ion elution was more efficient for purifying specific antibodies from the column in comparison to ]c elution. Dot blot analysis indicated that purified antibodies showed a high degree of reactivity with cattle filarial antigen and recombinant filarial protein but not with bacterial proteins of E. coli suggesting that the antibodies are specific.lld:pubmed
pubmed-article:9475043pubmed:languageenglld:pubmed
pubmed-article:9475043pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9475043pubmed:citationSubsetIMlld:pubmed
pubmed-article:9475043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9475043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9475043pubmed:statusMEDLINElld:pubmed
pubmed-article:9475043pubmed:monthOctlld:pubmed
pubmed-article:9475043pubmed:issn0019-5189lld:pubmed
pubmed-article:9475043pubmed:authorpubmed-author:WENH YHYlld:pubmed
pubmed-article:9475043pubmed:authorpubmed-author:NarayananR...lld:pubmed
pubmed-article:9475043pubmed:authorpubmed-author:KalirajPPlld:pubmed
pubmed-article:9475043pubmed:authorpubmed-author:KannanKKlld:pubmed
pubmed-article:9475043pubmed:authorpubmed-author:LalithaPPlld:pubmed
pubmed-article:9475043pubmed:issnTypePrintlld:pubmed
pubmed-article:9475043pubmed:volume35lld:pubmed
pubmed-article:9475043pubmed:ownerNLMlld:pubmed
pubmed-article:9475043pubmed:authorsCompleteYlld:pubmed
pubmed-article:9475043pubmed:pagination1076-9lld:pubmed
pubmed-article:9475043pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:meshHeadingpubmed-meshheading:9475043-...lld:pubmed
pubmed-article:9475043pubmed:year1997lld:pubmed
pubmed-article:9475043pubmed:articleTitleOptimisation of immunoaffinity purification of Wuchereria bancrofti specific antibodies from human sera.lld:pubmed
pubmed-article:9475043pubmed:affiliationCentre for Biotechnology, Anna University, Madras, India.lld:pubmed
pubmed-article:9475043pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9475043pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed